이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

환자가 경험하는 폐암에 대한 낙인을 없애기 위한 암 치료 제공자를 위한 공감적 의사소통 기술 교육

2026년 10월 6일 업데이트: Memorial Sloan Kettering Cancer Center

폐암 낙인 감소를 위한 공감적 의사소통 기술 훈련

Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.

연구 개요

상세 설명

The aims of this study are:

  1. to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);

  2. to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).

    Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and

  3. to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).

Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.

연구 유형

중재적

등록 (추정된)

1232

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • California
      • Irvine, California, 미국, 92612
        • 완전한
        • Providence St. Joseph Health (Data Collection Only)
    • Florida
      • Miami, Florida, 미국, 33143
        • 모병
        • BAPTIST ALLIANCE - MCI (Data Collection Only)
        • 연락하다:
          • Ian Bostock, MD
          • 전화번호: 786-596-2000
    • Illinois
      • Libertyville, Illinois, 미국, 60048
        • 모병
        • Advocate Health Care Network
        • 연락하다:
          • Michael Breen, MD
          • 전화번호: 847-367-6781
    • Kentucky
      • Lexington, Kentucky, 미국, 40536-0093
        • 완전한
        • University of Kentucky (Data Collection Only)
    • Michigan
      • Traverse City, Michigan, 미국, 49684
        • 완전한
        • Munson Healthcare (Data Collection Only)
    • New Jersey
      • Hackensack, New Jersey, 미국, 07601
        • 모병
        • Hackensack Meridian Health (Data collection only)
        • 연락하다:
          • David Greenberg, MD
          • 전화번호: 551-996-8704
    • New York
      • Buffalo, New York, 미국, 14263-0001
        • 모병
        • Roswell Park Cancer Institute (Data Collection Only)
        • 연락하다:
          • Elisabeth Dexter, MD
          • 전화번호: 716-845-2300
      • New York, New York, 미국, 10065
        • 모병
        • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        • 연락하다:
          • Smita Banerjee, PhD
          • 전화번호: 646-888-0011
    • Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19111
        • 모병
        • Fox Chase Cancer Center (Data Collection Only)
        • 연락하다:
          • Linda Fleisher, PhD, MPH
          • 전화번호: 215-728-4066
      • Philadelphia, Pennsylvania, 미국, 19104-4283
        • 모병
        • University of Pennsylvania (Data Collection Only)
        • 연락하다:
          • Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP
          • 전화번호: (215) 615-5858
      • Philadelphia, Pennsylvania, 미국, 08060
        • 완전한
        • Virtua Health (Data Collection Only)
    • Virginia
      • Chesapeake, Virginia, 미국, 23320
        • 모병
        • Chesapeake Regional Healthcare (Data Collection Only)
        • 연락하다:
          • Stephen Noble, MD
          • 전화번호: 757-842-4499

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

Site Eligibility

  • Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
  • Reports a clinic volume of at least 20 new lung cancer patients per month as per self report

OCP Participant Eligibility

  • OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
  • OCP conducts consultations with lung cancer patients, as per self-report;
  • OCP sees at least 1 lung cancer patient per week, as per self-report;

Patient Eligibility

  • Patient under the care of a participating OCP as per self report;

  • English and/or Spanish speaking;

    • In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
    • If English, treat as fluent in English, no additional language questions
    • If Spanish, treat as fluent in Spanish, no additional language questions
    • If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
    • How well do you speak English? Not at all/ Not well/Well/Very well
    • How well do you speak Spanish? Not at all/Not well/Well/Very well
  • Is at least 18 years of age as per self report;

  • Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;

  • Is a former or current smoking as per self report;

  • Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report

Exclusion Criteria:

Patient Exclusion

  • Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.

Site and OCP Exclusion

  • None

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 더블

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Oncology Care Providers/OCP-intervention group

Providers participate in Empathic Communication Skills (ECS) training

The overall training goal of this 2.25 hour module ECS module is to enhance OCP recognition and responsiveness to lung cancer patients' empathic opportunities by communicating understanding, alleviating stigma and distress, and providing support. The ECS training also provides tools to OCPs to buffer/inoculate patients against stigmatizing attitudes and behaviors by others such that lung cancer patients who currently or formerly smoked can be given "small doses" of an opposing viewpoint (termed as "preparing patients for recurring smoking questions") and suggestions of "counterarguments" in order to make them resistant to future stigmatizing attacks by others

활성 비교기: Oncology Care Providers/OCP-control group

Providers complete all study measures and are offered ECS training after data collection is completed at their site.

Standard of Care participant interaction

실험적: Participants with Lung Cancer-intervention group

Participants will engage with oncology care providers/OCP who have undergone Empathic Communication Skills (ECS) training

The overall training goal of this 2.25 hour module ECS module is to enhance OCP recognition and responsiveness to lung cancer patients' empathic opportunities by communicating understanding, alleviating stigma and distress, and providing support. The ECS training also provides tools to OCPs to buffer/inoculate patients against stigmatizing attitudes and behaviors by others such that lung cancer patients who currently or formerly smoked can be given "small doses" of an opposing viewpoint (termed as "preparing patients for recurring smoking questions") and suggestions of "counterarguments" in order to make them resistant to future stigmatizing attacks by others

활성 비교기: Participants with Lung Cancer-control group

Waitlist control group - WLC

Standard of Care participant interaction

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Uptake of communication skills using standardized patient assessment/SPAs
기간: 3 months

A SPA involves a 12-minute video recorded interaction between the Oncology Care Provider/OCP and the Standardized Patient/SP on a given clinical scenario, using standardized scripts by the SP. Each OCP will participate in one SPA prior to their ECS training and one SPA following training or the timed control period. In contrast to clinical consultation recordings with varied clinical situations that do not necessitate the use of all strategies and skills, the semi-structured nature of SPAs permits appraisal of all desired elements of training.

3 months
Uptake of empathy skills using standardized patient assessment/SPAs
기간: 3 months

A SPA involves a 12-minute video recorded interaction between the Oncology Care Provider/OCP and the Standardized Patient/SP on a given clinical scenario, using standardized scripts by the SP. Each OCP will participate in one SPA prior to their ECS training and one SPA following training or the timed control period. In contrast to clinical consultation recordings with varied clinical situations that do not necessitate the use of all strategies and skills, the semi-structured nature of SPAs permits appraisal of all desired elements of training.

3 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Smita Banerjee, PhD, Memorial Sloan Kettering Cancer Center

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2023년 4월 28일

기본 완료 (추정된)

2027년 8월 31일

연구 완료 (추정된)

2027년 8월 31일

연구 등록 날짜

최초 제출

2022년 7월 8일

QC 기준을 충족하는 최초 제출

2022년 7월 8일

처음 게시됨 (실제)

2022년 7월 13일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 7일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 10월 6일

마지막으로 확인됨

2026년 10월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다